Pathology Laboratory Services

Serving more than 5,500 patients each day, Miraca Life Sciences is a leading, academic-caliber anatomic pathology laboratory, providing diagnostic services in the fields of breast health, dermatology, gastroenterology, hematology and urology. Building on our experience with health IT, we also offer technology solutions and consulting services to assist clinicians with Meaningful Use initiatives and other reporting requirements.

Miraca Research & Development Services utilize our expertise and resources as a premier anatomic pathology commercial laboratory. Miraca’s difference is in our ability to draw upon the foundation of our commercial laboratory, to provide pathology, laboratory and data services.

We employ a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to you.

Pathology Research & Publications

Our skilled team of field-specific clinical pathologists, consultants and experts work diligently to stay at the forefront of the ever-changing landscape of a pathology laboratory and health IT. As part of this diligence, we work closely with one another to provide the highest quality, academic-based research and information possible.

Recent News


March 27, 2017

Simponi® is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life Sciences

IRVING, Texas, March 28, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand its InformTx™ therapeutic drug monitoring (TDM) capabilities, now testing for Simponi (golimumab) as well as patient-developed antibodies to Simponi. This is the first TDM assay available in the United States for Simponi. With this addition, Miraca Life Sciences now performs TDM […]

Continue reading


November 30, 2016

Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life Sciences

IRVING, Texas, December 1, 2016 — Miraca Life Sciences, the largest U.S. independent anatomic pathology lab, has expanded its InformTx™ therapeutic drug monitoring service for drugs that treat inflammatory bowel disease (IBD) with the addition of Stelara (ustekinumab).

Miraca Life Sciences continues to perform therapeutic drug monitoring (TDM) for Remicade® (infliximab), Humira® (adalimumab), Cimzia® (Certolizumab pegol) and Entyvio® (vedolizumab). Since […]

Continue reading


Miraca has made our life much easier by providing the necessary technology, the most professional service and excellent customer service. We have used different pathology labs in the past. Miraca is the most outstanding among all of them.
— Angela Wong, Office Manager, David S. Ho, MD, Urologist
Houston, Texas


READ MORE

Featured Subspecialty Expert


Saboorian

M.H. Saboorian, MD

Director of General Surgical Pathology and Cytology

more